课题基金 / 基金详情

Apoptosis and Necrosis in Pancreatitis

Apoptosis and Necrosis in Pancreatitis
胰腺炎中的细胞凋亡和坏死
批准号:
7064763
负责人:
ANNA S. GUKOVSKAYA
金额:
$17.66万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2008-03-31

项目摘要

项目成果

ANNA S. GUKOVSKAYA的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):炎症和实质组织损伤是胰腺炎的特征。尤其是严重的坏死是该病的主要并发症。在过去的十年中,在了解胰腺炎炎症反应的机制方面取得了重大进展。相比之下,人们对胰腺腺泡细胞死亡的机制知之甚少。坏死的机制在很大程度上是未知的。介导细胞凋亡的关键信号已经建立;然而,它们在疾病过程中的作用仍然不清楚,而且它们在胰腺炎中的作用还没有被研究。细胞死亡通路在胰腺炎组织损伤的重要标志--病理性胰酶激活中的作用尚未被探讨。我们的初步数据表明,在实验性胰腺炎模型和CCK刺激的胰腺腺泡细胞中,关键的坏死和凋亡机制:聚腺苷二磷酸核糖聚合酶(PARP)、线粒体功能障碍、半胱氨酸特异性半胱氨酸蛋白酶(Caspase)和转录因子NFkappaB被激活。对于目前的应用,我们假设在胰腺炎中,坏死性和凋亡性信号通路是相互关联的。PARP的激活和线粒体的失能导致了ATP的耗竭和坏死。另一方面,效应半胱氨酸氨基转移酶通过失活PARP和胰蛋白酶来介导细胞凋亡和限制坏死。NFkappaB负性调节效应半胱氨酸天冬氨酸酶,从而在胰腺炎中发挥抗细胞凋亡的作用。因此,PARP、线粒体功能障碍、caspase和NFkappaB在决定凋亡型和坏死型腺泡细胞死亡与胰腺炎严重程度之间的平衡中起着核心作用。我们为本申请提出了以下具体目标:1)。确定PARP在实验性胰腺炎和体外CCK刺激的胰腺腺泡细胞坏死和凋亡中的作用。2)。确定线粒体功能障碍在实验性胰腺炎和体外CCK刺激的胰腺腺泡细胞坏死和凋亡中的作用。3)确定caspase在实验性胰腺炎和体外CCK刺激的胰腺腺泡细胞坏死、凋亡和胰酶激活中的作用。4)。确定NFkappaB在实验性胰腺炎和体外CCK刺激的胰腺腺泡细胞坏死和凋亡中的作用。实现这些目标的措施将包括胰腺炎的测量,细胞凋亡和坏死的形态特征,胰腺内caspase和胰蛋白酶的激活,细胞色素c的释放,线粒体膜电位,ATP水平,以及使用Western印迹和凝胶位移分析,酶和荧光分析的NFkappaB激活。在提出的特定目标下的实验结果将描绘出调控急性胰腺炎坏死和凋亡的关键分子机制,这将导致治疗该疾病的新的治疗策略。
英文摘要
DESCRIPTION (provided by applicant): Inflammation and parenchymal tissue damage are hallmarks of pancreatitis. In particular, severe necrosis is a major complication of the disease. Over the past decade, significant progress has been achieved in understanding the mechanisms of the inflammatory response of pancreatitis. In contrast, very little is known about the mechanisms of pancreatic acinar cell death. Mechanisms of necrosis are largely unknown. Key signals mediating apoptosis have been established; however, their roles in disease processes remain obscure, and they have not been investigated in pancreatitis. The role of cell death pathways in pathologic trypsin activation, an important marker of tissue damage in pancreatitis, has not been explored. Our preliminary data indicate that key necrotic and apoptotic mechanisms: poly (ADP-ribose) polymerase (PARP), mitochondrial dysfunction, caspases (specific cysteine proteases), and the transcription factor NFkappaB are activated in experimental models of pancreatitis and in pancreatic acinar cells stimulated with cholecystokinin (CCK). For the present application, we hypothesize that in pancreatitis, necrotic and apoptotic signaling pathways are interrelated. Activation of PARP and mitochondrial de-energization leads to ATP depletion and necrosis. On the other hand, effector caspases mediate apoptosis and limit necrosis by inactivating PARP and trypsin. NFkappaB negatively regulates effector caspases and, thus plays an anti-apoptotic role in pancreatitis. Thus PARP, mitochondrial dysfunction, caspases, and NFkappaB play central roles in determining the balance between apoptotic versus necrotic type of acinar cell death and the severity of pancreatitis. We propose the following specific objectives for the present application: 1). Determine the role of PARP in necrosis and apoptosis in experimental pancreatitis and in vitro, in pancreatic acini stimulated with CCK. 2). Determine the role of mitochondrial dysfunction in necrosis and apoptosis in experimental pancreatitis and in vitro, in pancreatic acini stimulated with CCK. 3) Determine the role of caspases in necrosis, apoptosis, and trypsin activation in experimental pancreatitis and in vitro, in pancreatic acini stimulated with CCK. 4). Determine the role of NFkappaB in necrosis and apoptosis in experimental pancreatitis and in vitro, in pancreatic acini stimulated with CCK. Measurements to achieve these goals will include measures of pancreatitis, morphologic characterization of apoptosis and necrosis, intrapancreatic activation of caspases and trypsin, cytochrome c release, mitochondrial membrane potential, ATP levels, and NFkappaB activation by using Western blot and gel shift analyses, enzymatic and fluorimetric assays. The result of the experiments in the proposed specific objectives will be delineation of key molecular mechanisms regulating necrosis and apoptosis in acute pancreatitis, which will lead to novel therapeutic strategies to treat the disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
Dysregulated cholesterol homeostasis, caused by lysosomal/autophagy dysfunction, mediates pancreatitis
BLRD Research Career Scientist Award Application
BLRD Research Career Scientist Award Application
海外基金